HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea · Delayed Price · Currency is KRW 16,000
-130 (-0.81%)
Dec 10, 2025, 3:30 PM KST
-22.52% (1Y)
| Market Cap | 226.50B |
| Revenue (ttm) | 36.10B |
| Net Income (ttm) | 472.66M |
| Shares Out | 14.04M |
| EPS (ttm) | 34.13 |
| PE Ratio | 479.21 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 43,439 |
| Average Volume | 136,125 |
| Open | 16,010 |
| Previous Close | 16,130 |
| Day's Range | 15,890 - 16,100 |
| 52-Week Range | 12,500 - 33,250 |
| Beta | 0.49 |
| RSI | 53.22 |
| Earnings Date | Nov 13, 2025 |